Search Results for "Etanercept And Th17"
Original Source: Combined Treatment of Etanercept and MTX Reverses Th1/Th2, Th17/Treg Imbalance in Patients with Rheumatoid Arthritis.
OBJECTIVE: To explore the mechanism of Etanercept in the treatment of rheumatoid arthritis (RA), we investigated whether the Th1/Th2 and Th17/regulatory T cells (Treg) imbalance could be reversed by Etanercept and whether the reversal was related to the improvement of clinical indications. METHODS: We conducted a 12-week study in 40 active RA patients, of whom 20 were given a stable weekly dose of methotrexate (MTX) alone and the other ten received a combined therapy of Etanercept and MTX. Ten healthy donor...
Matching Channels
The IL-17 family consists of six ligands, A-F. IL-17 was originally thought to signal via the classic receptor IL-17R, but IL17 stimulates a receptor complex that consists of the subunits IL-17RA and...
Technical Background Tumor necrosis factor (TNF) is a substance made by your body's immune system. People with inflammatory diseases such as rheumatoid arthritis, plaque psoriasis, psoriatic a...
Crohns Disease is a chronic inflammatory disease, affecting the whole of the alimentary tract from mouth to anus, and all layers of the gut wall. The most commonly affected sites are the terminal il...
Matching News
Conventional or reduced doses of etanercept with methotrexate in patients with moderately active rheumatoid arthritis more effectively maintain low disease activity than does methotrexate alone after...
Methotrexate and Etanercept for Plaque Psoriasis
This study evaluated etanercept plus methotrexate vs. etanercept monotherapy in patients with moderate to severe plaque psoriasis. The British Journal of Dermatology
Induction and molecular signature of pathogenic TH17 cells
Exposure to interleukin 23 (IL-23) is required for the induction of pathogenic TH17 cells. Kuchroo and colleagues show that IL-23-dependent induction of the cytokine TGF-β3 produces a molecular signa...
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
TH17 cells (interleukin-17 (IL-17)-producing helper T cells) are highly proinflammatory cells that are critical for clearing extracellular pathogens and for inducing multiple autoimmune diseases. IL-2...
Low-Dose Etanercept May Not Stop RA Damage
Low-dose etanercept produces clinical control similar to that from standard dosing but does not prevent radiographic progression of joint damage. Medscape Medical News
Dynamic regulatory network controlling TH17 cell differentiation
A global view of the genetic networks regulating the differentiation of TH17 cells is presented, based on temporal expression profiling, computational network reconstruction and validation of predicte...
T cells: Salt promotes pathogenic TH17 cells
A high-salt diet triggers the development of pathogenic TH17 cells and accelerates multiple sclerosis-like disease in mice.
Etanercept, adalimumab equal in RA, unless antibodies develop
NEW YORK (Reuters Health) - Etanercept and adalimumab appear similarly effective against rheumatoid arthritis (RA) in patients who haven't been treated with anti-TNF agents, Dutch researchers say.
Matching PubMed Articles
PURPOSE: To evaluate circulating and lesional CD4(+) and CD8(+) cells belonging to Th1, Th2, and Th17 patterns as well as IL-10(+) cells before and after a 12-week lasting course with etanercept or ac...
OBJECTIVE: To explore the mechanism of Etanercept in the treatment of rheumatoid arthritis (RA), we investigated whether the Th1/Th2 and Th17/regulatory T cells (Treg) imbalance could be reversed by E...
Background: Psoriasis is sustained by pro-inflammatory CD4+ T helper cells mainly belonging to the Th1, Th17 and Th22 lineage. Objective: To identify whether treatment with the anti-tumour-necrosis-fa...
Interleukin-20 antibody is a potential therapeutic for experimental arthritis.
OBJECTIVE:: Interleukin (IL)-20 is a proinflammatory cytokine involved in the pathogenesis of rheumatoid arthritis (RA). We investigated whether anti-IL-20 antibody treatment would modulate the severi...
Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment.
In several murine models of autoimmune arthritis, Th17 cells are the dominant initiators of inflammation. In human arthritis the majority of IL-17-secreting cells within the joint express a cytokine p...
